Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone to Reduce Preterm Birth in HIV-Infected Pregnant Women
NCT02970552Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of progesterone in preterm birth, sponsored by University of North Carolina at Chapel Hill. Started Jul 2017; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT02970552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02970552.